Centro Odontologico Del Sureste Slp
Murcia, 30007, Spain
Location status: Recruiting
Location contact
Antonio J Ortiz-Ruiz, MD
CONTACT
Jose A Moreno-Rodriguez
CONTACT
NCT Number: NCT05237570
This study aims to describe a new approach for the reconstruction of the alveolar process in the sinus area. This minimally invasive approach will access the maxillary sinus through the alveolar process, elevating the sinus membrane in the area immediately above it. The regeneration may be achieved in the specific area required for dental implant placement, reducing the morbidity of the procedure.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Murcia, 30007, Spain
Location status: Recruiting
Antonio J Ortiz-Ruiz, MD
CONTACT
Jose A Moreno-Rodriguez
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this group, the maxillary sinus will be accessed through a window in the interradicular septum and the membrane will be elevated, carrying out the regeneration of the area to facilitate subsequent implant placement.
Time frame: 9 months
Bone height change
Time frame: 9 months
Bucco-palatal bone width change
Contact information is provided by the study sponsor or research team.
Antonio J Ortiz-Ruiz, MD
CONTACT
José A Moreno-Rodriguez, DDS
CONTACT
Universidad de Murcia
Other
Minimally Invasive Microsurgical Sinus-lift Through the Interradicular Septum. A Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05961371
Behavior, Bone Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT05764733
Body Weight, Body Weight Changes
Aurora, Colorado, United States
View Trial DetailsNCT06541548
Bone Diseases, Bone Diseases, Metabolic
Saint-Etienne, France
View Trial DetailsNCT05303636
Bone Diseases, Bone Diseases, Metabolic
Phoenix, Arizona, United States
View Trial Details